Racing to block tumorigenesis after pRb loss: an innocuous point mutation wins with synthetic lethality.
Racing to block tumorigenesis after pRb loss: an innocuous point mutation wins with synthetic lethality.
复制标题
DOI:
10.4161/cc.9.11.11726
复制
发表时间:
2010-06-01
期刊:
影响因子:
--
通讯作者:
Zhu L
中科院分区:
文献类型:
--
作者:
Bauzon F;Zhu L
A major goal of tumor suppressor research is to neutralize the tumorigenic effects of their loss. Since loss of pRb does not induce tumorigenesis in many types of cells, natural mechanisms may neutralize the tumorigenic effects of pRb loss in these cells. For susceptible cells, neutralizing the tumorigenic effects of pRb loss could logically be achieved by correcting the deregulated activities of pRb targets to render pRb-deficient cells less abnormal. This line of research has unexpectedly revealed that knocking out the pRb target Skp2 did not render Rb1 deficient cells less abnormal but, rather, induced apoptosis in them, thereby completely blocking tumorigenesis in Rb1+/- mice and after targeted deletion of Rb1 in pituitary intermediate lobe (IL). Skp2 is a substrate-recruiting component of the SCFSkp2 E3 biquitin ligase; one of its substrates is Thr187-phosphorylated p27Kip1. A p27T187A knockin (KI) mutation phenocopied Skp2 knockout (KO) in inducing apoptosis following Rb1 loss. Thus, Skp2 KO or p27T187A KI are synthetic lethal with pRb inactivation. Since homozygous p27T187A KI mutations show no adverse effects in mice, inhibiting p27T187 phosphorylation or p27T187p ubiquitination could be a highly therapeutic and minimally toxic intervention strategy for pRb deficiency-induced tumorigenesis.
登录
查看更多内容
影响因子:
64.8
作者:
Laurie, Nikia A.;Donovan, Stacy L.;Dyer, Michael A.
通讯作者:
Dyer, Michael A.
DOI:
10.1073/pnas.0805462105
发表时间:
2008-08-19
影响因子:
11.1
作者:
Berman, Seth D.;Calo, Eliezer;Lees, Jacqueline A.
通讯作者:
Lees, Jacqueline A.
影响因子:
64.8
作者:
Lowe, SW;Cepero, E;Evan, G
通讯作者:
Evan, G
影响因子:
10.5
作者:
MacPherson, D;Sage, J;Jacks, T
通讯作者:
Jacks, T
影响因子:
64.5
作者:
Luo J;Emanuele MJ;Li D;Creighton CJ;Schlabach MR;Westbrook TF;Wong KK;Elledge SJ
通讯作者:
Elledge SJ